Concorde Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Buy
158,210
+20,525
+15% +$102K 0.43% 47
2026
Q1
$650K Buy
137,685
+1,179
+0.9% +$6.15K 0.32% 69
2025
Q4
$683K Buy
136,506
+9,831
+8% +$51.2K 0.27% 84
2025
Q3
$687K Buy
+126,675
New +$558K 0.29% 76
2024
Q4
Sell
-85,975
Closed -$503K 194
2024
Q3
$503K Buy
85,975
+19,273
+29% +$95K 0.28% 63
2024
Q2
$287K Buy
66,702
+13,002
+24% +$62.3K 0.18% 105
2024
Q1
$252K Buy
53,700
+26,546
+98% +$102K 0.17% 111
2023
Q4
$133K Buy
+27,154
New +$133K 0.09% 154

Other funds holding MPT

Concorde Asset Management's MPT Position: Q2 2026 in Review

Concorde Asset Management increased its Medical Properties Trust (MPT) stake by 15% in Q2 2026, buying an estimated $102K and bringing the position to 158,210 shares worth $745K. The position accounts for 0.43% of the portfolio, ranked #47.

Concorde Asset Management first reported a position in MPT in Q4 2023 and has held it in 8 quarters since. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Concorde Asset Management held 158,210 shares of Medical Properties Trust worth $745K as of Q2 2026.
  • Concorde Asset Management bought 20,525 Medical Properties Trust shares in Q2 2026, an estimated $102K.
  • Medical Properties Trust made up 0.43% of Concorde Asset Management's portfolio in Q2 2026, its #47 holding.
  • Concorde Asset Management first reported a position in Medical Properties Trust in Q4 2023 and has held it in 8 quarters since.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Concorde Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.